Stay updated on Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page.

Latest updates to the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page
- Check3 days agoChange DetectedSchizophrenia has been added as a topic. The related topic MedlinePlus Genetics has been added as well.SummaryDifference0.1%

- Check10 days agoChange DetectedDeleted references to Schizophrenia and the MedlinePlus Genetics related topics section from the page.SummaryDifference0.1%

- Check17 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the page, reflecting a site revision update. No study-specific data or outcomes appear to be changed.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded the keywords 'Schizophrenia' and the related topic 'MedlinePlus Genetics' to the study record to enhance indexing and context.SummaryDifference0.1%

- Check46 days agoChange DetectedSchizophrenia and MedlinePlus Genetics topics were removed from the page's taxonomy/navigation. This metadata change does not modify the study details.SummaryDifference0.1%

Stay in the know with updates to Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page.